News Center

News Center

Focus · Conveyance
EU CE Compliance | Jinhao Pharmaceutical’s Nipah Virus Nucleic Acid Detection Kit Supports Research and Disease Prevention

2026.02.06

EU CE Compliance | Jinhao Pharmaceutical’s Nipah Virus Nucleic Acid Detection Kit Supports Research and Disease Prevention

EU CE Compliance | Jinhao Pharmaceutical’s Nipah Virus Nucleic Acid Detection Kit Supports Research and Disease Prevention

2026-02-06

EU CE Compliance | Jinhao Pharmaceutical’s Nipah Virus Nucleic Acid Detection Kit Supports Research and Disease Prevention

An outbreak of Nipah virus has occurred in India, and Jinhao Pharmaceutical’s all‑premixed nucleic acid assay combined with colloidal gold antigen tests is supporting epidemic monitoring and control.

2026-01-26

An outbreak of Nipah virus has occurred in India, and Jinhao Pharmaceutical’s all‑premixed nucleic acid assay combined with colloidal gold antigen tests is supporting epidemic monitoring and control.

World AIDS Day | Social Co-Governance, Upholding Core Principles While Innovating, Ending AIDS

2025-12-01

World AIDS Day | Social Co-Governance, Upholding Core Principles While Innovating, Ending AIDS

With the current chikungunya outbreak, Jinhao Pharmaceutical’s precise testing is supporting scientific prevention and control.

2025-07-25

With the current chikungunya outbreak, Jinhao Pharmaceutical’s precise testing is supporting scientific prevention and control.

Good News │ Beijing Jinhao Pharmaceutical Has Been Awarded the 2021 Beijing Science and Technology Progress Award!

2022-12-15

Good News │ Beijing Jinhao Pharmaceutical Has Been Awarded the 2021 Beijing Science and Technology Progress Award!

Beijing Jinhao Pharmaceutical’s real-time fluorescent quantitative PCR analyzer has obtained a Class III medical device registration certificate.

2022-10-25

Beijing Jinhao Pharmaceutical’s real-time fluorescent quantitative PCR analyzer has obtained a Class III medical device registration certificate.